Aquestive Therapeutics, Inc. (AQST)

Aquestive Therapeutics Revenue

Aquestive Therapeutics had revenue of $7.56M in the quarter ending September 30, 2026, a decrease of -40.99%. This brings the company's total for the last twelve months to $48.84M, up 12.54% year-over-year. In the year 2025, Aquestive Therapeutics had annual revenue of $44.55M, down -22.61%. That makes Aquestive Therapeutics the 28,181st largest company in the world by revenue and 3,804th in the United States.

• Revenue (ttm): $48.84M
• Revenue Growth: +12.54%
• P/S Ratio: 10.06
• Revenue / Employee: $332,224
• Employees: 147
• Market Cap: 491.44M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 29.60M 66.5%
• Ex-United States 14.94M 33.5%

Fiscal year ended Dec 31, 2025 See the full Aquestive Therapeutics breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	44.55M	-13.02M	-22.61%
Dec 31, 2024	57.56M	6.98M	13.80%
Dec 31, 2023	50.58M	2.90M	6.09%
Dec 31, 2022	47.68M	-3.15M	-6.20%
Dec 31, 2021	50.83M	4.98M	10.87%
Dec 31, 2020	45.85M	-6.76M	-12.85%
Dec 31, 2019	52.61M	-14.82M	-21.98%
Dec 31, 2018	67.43M	512.00K	0.77%
Dec 31, 2017	66.92M	15.13M	29.22%
Dec 31, 2016	51.79M	49.07M	1,807.37%
Dec 31, 2006	2.72M	592.00K	27.89%
Dec 31, 2005	2.12M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Nov 3, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 14, 2026

Data Sources Report a data error